A

TrkC Is Essential for Nephron Function and Trans-Activates Igf1R Signaling

Journal of the American Society of Nephrology, vol. 32, pp. 357–374

Abstract

Background Injury to kidney podocytes often results in chronic glomerular disease and consecutive nephron malfunction. For most glomerular diseases, targeted therapies are lacking. Thus, it is important to identify novel signaling pathways contributing to glomerular disease. Neurotrophic tyrosine kinase receptor 3 ( TrkC ) is expressed in podocytes and the protein transmits signals to the podocyte actin cytoskeleton. Methods Nephron-specific TrkC knockout ( TrkC-KO ) and nephron-specific TrkC -overexpressing ( TrkC-OE ) mice were generated to dissect the role of TrkC in nephron development and maintenance. Results Both TrkC-KO and TrkC-OE mice exhibited enlarged glomeruli, mesangial proliferation, basement membrane thickening, albuminuria, podocyte loss, and aspects of FSGS during aging. Igf1 receptor (Igf1R)–associated gene expression was dysregulated in TrkC-KO mouse glomeruli. Phosphoproteins associated with insulin, erb-b2 receptor tyrosine kinase (Erbb), and Toll-like receptor signaling were enriched in lysates of podocytes treated with the TrkC ligand neurotrophin-3 (Nt-3). Activation of TrkC by Nt-3 resulted in phosphorylation of the Igf1R on activating tyrosine residues in podocytes. Igf1R phosphorylation was increased in TrkC-OE mouse kidneys while it was decreased in TrkC-KO kidneys. Furthermore, TrkC expression was elevated in glomerular tissue of patients with diabetic kidney disease compared with control glomerular tissue. Conclusions Our results show that TrkC is essential for maintaining glomerular integrity. Furthermore, TrkC modulates Igf-related signaling in podocytes.

Authors 14

  1. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

  2. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

  3. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

  4. University of Münster

    Affiliation as printed

    Medical Faculty, Core Facility Transgenic Animal and Genetic Engineering Models (TRAM), Westfälische-Wilhelms-University, Münster, Germany

  5. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

  6. University Hospital Münster

    Affiliation as printed

    Gerhard-Domagk Institute for Pathology, University Hospital Münster, Münster, Germany

  7. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

  8. University Medical Center Hamburg-Eppendorf

    Affiliation as printed

    III. Medizinische Klinik und Poliklinik, University Hospital Hamburg-Eppendorf, Germany

  9. München Klinik Harlaching

    Affiliation as printed

    Klinik für Nieren-, Hochdruck- und Rheumaerkrankungen, München Klinik Harlaching, Germany

  10. Max Planck Institute for Molecular Biomedicine

    Affiliation as printed

    Mass Spectrometry Unit, Max Planck Institute for Molecular Biomedicine, Münster, Germany

  11. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    Institute of Pathology and Department of Nephrology, University Hospital Aachen, Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany

  12. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

  13. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

  14. University Hospital Münster

    Affiliation as printed

    Medizinische Klinik D, University Hospital Münster, Münster, Germany

Cited by 9 stored of 9

9 results

No patents citing this paper on Lens.org (checked 2026-10-06).

References 76